Detalles de la búsqueda
1.
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
BMC Cancer
; 20(1): 1091, 2020 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33176725
2.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901076
3.
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 175(3): 617-625, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868391
4.
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis.
Breast Cancer Res Treat
; 173(2): 319-328, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324275
5.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30603996
6.
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
BMC Cancer
; 18(1): 204, 2018 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463222
7.
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Geburtshilfe Frauenheilkd
; 84(1): 77-85, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178900
8.
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.
Eur J Cancer
; 155: 1-12, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34311211
9.
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.
J Clin Oncol
; 39(15): 1619-1630, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780288
10.
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
Cancers (Basel)
; 12(10)2020 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33080911
11.
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.
Breast
; 54: 88-95, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32956934
12.
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.
Geburtshilfe Frauenheilkd
; 80(11): e289, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262544
13.
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.
Geburtshilfe Frauenheilkd
; 80(11): 1134-1142, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33173241
14.
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.
Clin Cancer Res
; 26(12): 2986-2996, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32098767
15.
Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study).
Geburtshilfe Frauenheilkd
; 78(12): 1283-1291, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30686833
16.
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.
Breast Care (Basel)
; 13(1): 8-14, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29950961
17.
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
Cancers (Basel)
; 11(1)2018 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30577662
18.
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
Breast
; 37: 42-51, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100043
19.
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.
Breast
; 37: 154-160, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29237546
20.
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.
Geburtshilfe Frauenheilkd
; 77(8): 870-878, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28845051